Top Markets
Coin of the day
Radiopharm Theranostics Limited Radiopharm Theranostics Limited

Radiopharm Theranostics Limited

RAD
Clasificación en acciones #29694
Radiopharm Theranostics Limited a clinical-stage radiotherapeutics company,... Radiopharm Theranostics Limited a clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs. The company develops several products, including RAD101, a pivalate brain metastasis diagnostic; RAD102, a pivalate therapeutic; RAD201a, a Nano-mAb HER-2 breast diagnostic; RAD202, a Nano-mAb HER-2 breast therapeutic; RAD203, a Nano-mAb PDL1 non-small cell lung diagnostic; and RAD204, a Nano-mAb PDL1 non-small cell lung therapeutic. Additionally, it is developing RAD301 and RAD302, which are Avß6-Integrin pancreatic diagnostic and therapeutic products; RAD401, a PSA-mAb prostate cancer diagnostic; RAD402, a PSA-mAb prostate cancer therapeutic; RAD601, a PTPµ glioblastoma diagnostic; and RAD602, a PTPµ glioblastoma therapeutic. The company has a strategic agreement with Lantheus Holdings, Inc. to advance the clinical development of radiopharmaceuticals. The company was incorporated in 2021 and is based in Carlton, Australia.
Precio por acción
$0.00846342
Capitalización bursátil
$20.02M
Cambio (1 día)
0.00%
Cambio (1 año)
-47.56%
País
AU
Comercio Radiopharm Theranostics Limited (RAD)

Categoría

Historial del precio de la acción de Radiopharm Theranostics Limited (RAD)
Precio más alto de cierre: $0.01 el 2026-08-01

Precio más bajo de cierre: $0.24 el 2021-11-01
Historial del precio de la acción de Radiopharm Theranostics Limited desde 2021 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) -22.80%
2025 -10.60%
2024 -63.52%
2023 -27.28%
2022 -71.97%
2021 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$527.89 35.09%
US
$996.61 51.72%
NL
$117.42 -19.34%
AU
$735.86 6.07%
CH
$1.07K -5.58%
KR